Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Scott Christopher K., Chief Financial Officer. Insider active across 1 company, notably Iradimed CORP. In total, 5 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €846k. History available since 15 November 2021. The latest transaction was disclosed on 11 February 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Christopher K. Scott is CFO and Secretary of Iridimed Corp. In this role, he is responsible for the company's financial management, including financial planning and analysis. His expertise in finance is crucial for the development and growth of the company.